Immune Tolerance Network (UM1 Clinical Trial Required)
Agency: National Institutes of Health
- 93.855 -- Allergy and Infectious Diseases Research
Open opportunityLast Updated: Oct 26, 2026
Important dates
- Closing: January 29, 2027
Award details
- Expected project funding: $27,000,000
- Expected awards: 1
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-AI-28-005
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: October 20, 2026
- Archive date: March 29, 2027
- Version: 2
Summary
Jump to documentsThe purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.
Eligibility
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Miscellaneous
- Other
Government
- City or township governments
- Federally recognized Native American tribal governments
- Special district governments
- Public and Indian housing authorities
- County governments
- State governments
Business
- For-profit organizations other than small businesses
- Small businesses
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-AI-28-005-Full-Announcement.html | RFA-AI-28-005-Full-Announcement.html | Oct 20, 2026 10:47 AM UTC |
Agency contact information
Email: ITN_UM1@mail.nih.gov
ITN_UM1@mail.nih.gov
Link to additional information
No additional information is available
